- | A RNA nanotechnology platform for a two-in-one siRNA delivery and its application in synergistic RNAi therapy | Ahn Hyung Jun |
2019-12 | All-trans Retinoic Acid Overcomes Acquired Resistance to PLX4032 via Inhibition of PIN1 in Melanoma Cells | Kim, Garam; Bhattarai, Poshan Yugal; Oh, Chang-Hyun; Choi, Hong Seok |
2018-11-01 | CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer | Byeon, Yeongseon; Lee, Jeong-Won; Choi, Whan Soo; Won, Ji Eun; Kim, Ga Hee; Kim, Min Gi; Wi, Tae In; Lee, Jae Myeong; Kang, Tae Heung; Jung, In Duk; Cho, Young-Jae; Ahn, Hyung Jun; Shin, Byung Cheol; Lee, Young Joo; Sood, Anil K.; Han, Hee Dong; Park, Yeong-Min |
2018-10 | Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development | Jo, Yeonho; Choi, Nakwon; Kim, Kyobum; Koo, Hyung-Jun; Choi, Jonghoon; Kim, Hong Nam |
- | Enhanced cancer therapy by delivering self-assembled RNAi nanoparticles against multiple targets and chemotherapeutic agent to overcome chemoresistance | MIHUE JANG; Ahn Hyung Jun |
2020-04 | Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells | Rahman, Md. Ataur; Saha, Subbroto Kumar; Rahman, Md Saidur; Uddin, Md Jamal; Uddin, Md. Sahab; Pang, Myung-Geol; Rhim, Hyewhon; Cho, Ssang-Goo |
2022-06 | Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma | Poudel, Muna; Kim, Garam; Bhattarai, Poshan Yugal; Shin, Seung; Zaraei, Seyed-Omar; Oh, Chang-Hyun; Choi, Hong Seok |